transcriptional repression atherogenic inflammation: modulation ppar delta
formation atherosclerotic lesion mediated lipid-laden macrophages foam cells also establish chronic inflammation associated lesion progression peroxisome proliferator-activated receptor ppar gamma promotes lipid uptake efflux atherogenic cells contrast found closely related receptor ppardelta controls inflammatory status macrophage deletion ppardelta foam cells increased availability inflammatory suppressors turn reduced atherosclerotic lesion area % propose unconventional ligand-dependent transcriptional pathway ppardelta controls inflammatory switch association disassociation transcriptional repressors ppardelta ligands may thus serve therapeutic targets attenuate inflammation slow progression atherosclerosis
